Back to results
CompletedPhase 2

Atomoxetine Treatment for Cognitive Impairment in Parkinson's Disease (ATM-Cog)

NCT01738191

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Medical University of South Carolina

Charleston, South Carolina, United States

View on ClinicalTrials.gov
Atomoxetine Treatment for Cognitive Impairment in Parkinson's Disease (ATM-Cog) — TrialFind